1. Clinical outcomes and 30-day mortality following significant upper gastrointestinal bleeding in users of anti-platelet agents and non-steroidal anti-inflammatory drugs. (13th March 2011) Authors: Taha, A S; McCloskey, C; Craigen, T; Angerson, W Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mortality following blood transfusion for non-variceal upper gastrointestinal bleeding. (13th March 2011) Authors: Taha, A S; McCloskey, C; Craigen, T; Angerson, W; Shah, A A; Morran, C G Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-015 Nicorandil Does not Worsen Non-Variceal Upper Gastrointestinal Bleeding (NVUGIB) in Patients Taking Aspirin or Antithrombotic Drugs (ATDs). (17th August 2016) Authors: Taha, AS; McCloskey, C; Craigen, T; Simpson, A; Angerson, WJ Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-056 Long-Term Trends in Comorbidity and Risk Scores and their Influence on outcomes of upper Gastrointestinal Bleeding. (4th June 2013) Authors: Taha, A S; Saffouri, E; McCloskey, C; Craigen, T; Angerson, W J Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PTU-019 Antithrombotic Vs. Ulcer Effects In Non-variceal Bleeding In Users Of Antithrombotic Drugs. (9th June 2014) Authors: Taha, AS; McCloskey, C; Craigen, T; Angerson, WJ Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PTU-020 Antithrombotic Drugs And Non-variceal Bleeding Outcomes And Risk Scoring Systems – Comparison Of Blatchford, Rockall, And Charlson Scores. (9th June 2014) Authors: Taha, AS; McCloskey, C; Craigen, T; Angerson, WJ Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PTU-021 Occult vs. overt upper gastrointestinal bleeding – inverse relationship and the use of mucosal damaging and protective drugs. (22nd June 2015) Authors: Taha, AS; McCloskey, C; Craigen, T; Simpson, A; Angerson, WJ Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PTU-029 Bowel cancer screening and the use of aspirin and non-steroidal anti-inflammatory drugs (nsaids) – prospective population based analysis. (17th June 2017) Authors: Taha, AS; Diament, RH; McCloskey, C; Craigen, T; Simpson, A; Carrigan, A; Freeburn, L; Angerson, WJ Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PTU-030 Small bowel and other gi lesions in obscure gastro-intestinal bleeding – low dose aspirin vs. nsaids. screening phase of the masters trial. (17th June 2017) Authors: Taha, AS; McCloskey, C; Craigen, T; Simpson, A; Carrigan, A; Freeburn, L; Angerson, WJ Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PWE-157 Upper gastrointestinal bleeding in hospitalised patients—prospective controlled analysis of the role of aspirin and other antithrombotic drugs. (28th May 2012) Authors: Taha, A S; Kelly, C; McCloskey, C; Craigen, T; Angerson, W J Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗